Pharmaron Beijing Co Ltd (300759) — Cash Flow Quality Index
Pharmaron Beijing Co Ltd (300759) has a Cash Flow Quality Index of 2.36x as of September 2025. Operating cash flow of CN¥1.04 Billion exceeds net income of CN¥439.52 Million, indicating high earnings quality where cash backs reported profits. Explore 300759 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pharmaron Beijing Co Ltd Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for Pharmaron Beijing Co Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Pharmaron Beijing Co Ltd generate cash.
Annual Cash Flow Quality Index for Pharmaron Beijing Co Ltd (2014–2024)
Year-by-year earnings quality comparison for Pharmaron Beijing Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.50x | CN¥2.58 Billion | CN¥1.71 Billion | ▼ -12.6% |
| 2023 | 1.72x | CN¥2.75 Billion | CN¥1.60 Billion | ▲ +8.5% |
| 2022 | 1.58x | CN¥2.14 Billion | CN¥1.35 Billion | ▲ +24.8% |
| 2021 | 1.27x | CN¥2.06 Billion | CN¥1.62 Billion | ▼ -11.6% |
| 2020 | 1.44x | CN¥1.65 Billion | CN¥1.15 Billion | ▼ -18.7% |
| 2019 | 1.77x | CN¥938.59 Million | CN¥530.67 Million | ▼ -18.7% |
| 2018 | 2.17x | CN¥737.26 Million | CN¥339.03 Million | ▼ -10.6% |
| 2017 | 2.43x | CN¥552.22 Million | CN¥227.02 Million | ▲ +82.5% |
| 2016 | 1.33x | CN¥235.77 Million | CN¥176.91 Million | ▼ -54.6% |
| 2015 | 2.94x | CN¥216.94 Million | CN¥73.85 Million | ▲ +408.3% |
| 2014 | 0.58x | CN¥12.13 Million | CN¥21.00 Million | — |